No Data
No Data
Melodiol Global Health Full Year 2023 Earnings: AU$0.019 Loss per Share (Vs AU$0.45 Loss in FY 2022)
MELODIOL GLOBAL HEALTH LIMITED To Carry Out 1-for-20 Reverse Stock Split On January 25th, 2024
December 23rd - $MELODIOL GLOBAL HEALTH LIMITED(COPHF.US)$ is about to implement a 1-for-20 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from January 25th, 20
Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research A milestone in psychedelics education was achieved: The Energia Foundation, organizer of the same conversation within this Ja
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
Australia-based cannabis and psychedelics company Creso Pharma Ltd. (OTC:COPHF) inked a Letter of Intent (LOI) with Swiss pharmacy Apotheke Dr. Hysek AG toward an exclusive partnership for the import
Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
Cannabis company Creso Pharma (OTC:COPHF)'s wholly-owned psychedelics subsidiary Halucenex Life Sciences Inc. shared promising early findings on its ongoing Phase 2 clinical trial assessing the effica
Proactive News Headlines Including Antilles Gold, AuTECO Minerals, Latin Resources and HyTerra Ltd
Sydney, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Antilles Gold Ltd ((ASX:AAU,
No Data